ILMN
Illumina, Inc (ILMN) Illumina partners go beyond the genome, driving cancer breakthroughs using spatial transcriptomics, epigenomics, and proteomics
Illumina, Inc (NASDAQ: ILMN) FY 2026 Other Release
Illumina, Inc (ILMN) Illumina launches TruPath Genome, setting a new standard in genomic insight
Illumina, Inc (NASDAQ: ILMN) FY 2026 Other Release
Illumina, Inc (ILMN) Illumina Unveils Roadmap Of Groundbreaking Novaseq X Advancements In Data Quality, Output, Speed, And Flexibility
Illumina, Inc (NASDAQ: ILMN) FY 2026 Other Release
Illumina, Inc (ILMN) Q4 2025 Earnings Call
Illumina, Inc (NASDAQ: ILMN) Q3 2025 Earnings Conference
Illumina, Inc (ILMN) Q4 2025 Earnings Call
Illumina, Inc (NASDAQ: ILMN) Q3 2025 Earnings Conference
Illumina, Inc (ILMN) TD Cowen 46th Annual Health Care Conference 2026
Illumina, Inc (NASDAQ: ILMN) FY 2026 Corporate Conference
Illumina, Inc (ILMN) Sec Form 10K
Illumina, Inc (NASDAQ: ILMN) Sec Form 10K
Illumina, Inc (ILMN) AI, Genomics, and CRISPR Signal a New Phase of Biological Innovation
Illumina, Inc (NASDAQ: ILMN) FY 2026 Other Release
Illumina, Inc (ILMN) Sec Form 8K
Illumina, Inc (NASDAQ: ILMN) Sec Form 8K